Search For A Cure
Scientific Breakthroughs & Caregiver Tips
Alcoholism Brain Science
Clinical Trials.gov has hundreds of trials listed on its site that involve alcohol dependence. One of these trials is testing a hallucinogen called psilocybin, a mushroom derivative, against a control, a known allergy medication called diphenhydramine. This trial, which will be blinded to all 180 participants, meaning that trial investigators and participants will not know who has taken what substance, is designed for various outcomes, including how the patients react short-term to various amounts of psilocybin. Investigators, who include New York University Langone Medical Center, also want to evaluate patients’ drinking before and after receiving the hallucinogen. Your donations help support this research.
Michael P. Bogenschutz, MD
Michael Bogenschutz, MD is an addiction psychiatry specialist at NYU Langone and has been practicing for 30 years. He graduated from Harvard Medical S…Read More…
The question is how do some people make profound changes in their addictive behaviors…
– Michael P. Bogenschutz, MD
Make a Donation, Make a Difference
Your Donation Supports Crucial Brain Research
We have a direct connection with scientists so we are privy to projects in all stages of research. This gives us the insight to identify projects and allocate the dollars needed to find cures. Donate generously today to make a difference for future generations and your loved ones.
YOUR DONATION SAVES LIVES & BRINGS US CLOSER TO A CURE.
You Are Not Alone
For you or a loved one to be diagnosed with a brain disease or disorder, is overwhelming, and it leads to a quest for support and answers to very important questions. ABS has built a safe, caring and compassionate community for you to share your journey, connect with others in similar situations, learn about breakthroughs, and to simply find comfort.